Dynatrace Inc SEC Filings

Dynatrace, Inc. (DT) Form 144 notifies a proposed sale of 7,506 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $373,306.41, and an approximate sale date of 09/09/2025. The filing lists 301,506,242 shares outstanding. The shares to be sold were acquired on 09/05/2025 as 4,651 performance shares and 2,855 restricted stock. The filing also discloses a prior sale by Daniel J. Zugelder of 15,822 shares on 07/01/2025 for $867,702.21. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

Dynatrace director Lisa M. Campbell reported the vesting of 2,025 time‑based restricted stock units on 09/04/2025, each convertible into one share of the company’s common stock. On 09/05/2025 she sold 1,013 shares at $49.77 per share pursuant to a Rule 10b5-1 trading plan adopted May 16, 2025. After these transactions she beneficially owns 6,074 shares. The RSUs that vested were part of a grant dated 09/04/2024; 25% vested on 09/04/2025 and the remainder vests quarterly thereafter, subject to continued service.

Dynatrace insider sale: SVP and Chief Accounting Officer Daniel S. Yates sold 2,000 shares of Dynatrace, Inc. (DT) on 09/04/2025 at $49.89 per share under a pre-established Rule 10b5-1 plan. After the reported disposition, Mr. Yates beneficially owned 22,555 shares, held directly. The filing notes the 10b5-1 trading plan was adopted on June 5, 2025, and the Form 4 was signed by a power of attorney on 09/05/2025. The disclosure is a routine officer sale and does not include any derivative transactions or additional pledges reported on this form.

Dynatrace, Inc. (DT) filed a Form 144 indicating a proposed sale of 1,013 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an approximate sale date of 09/05/2025. The filing reports an aggregate market value of $50,417.01 and shows 301,506,242 shares outstanding, implying the sale is a very small fraction of the company's share count. The shares were acquired as restricted stock from the issuer on 09/04/2025 and payment is recorded as made on 09/04/2025. The filer reports no other securities sold in the past three months and includes the standard attestation that no undisclosed material adverse information is known.

Dynatrace director Amol Kulkarni received 519 vested restricted stock units (RSUs) that converted into common stock on 09/01/2025, increasing his direct beneficial ownership to 4,150 shares. The Form 4 shows the RSUs were part of a grant made on 09/01/2023; 25% of that grant vested on 09/01/2024 and the remainder vests in equal quarterly installments thereafter, subject to continued service. The filing was signed by power of attorney on 09/03/2025. The RSUs are described as non-expiring contingent rights to one share each.

Dynatrace director Michael L. Capone reported insider equity changes on Form 4. The filing shows certain unvested time-based restricted stock units (RSUs) previously reported in Table I were moved to Table II as derivative securities. A decrease of 3,981 common shares reflects RSUs reclassified; separately, 3,981 RSUs vested on 08/20/2025 and were reported as settled, and a new grant of 4,111 RSUs was reported that will vest on the earlier of the one-year anniversary of grant or the 2026 Annual Meeting, subject to continued service. The Form is signed by power of attorney on 08/21/2025.

Dynatrace director Kirsten O. Wolberg reported changes in her equity holdings. The Form 4 shows a reclassification of 3,981 previously reported unvested restricted stock units (RSUs) from the non-derivative table to the derivative table and notes that 100% of those RSUs vested on August 20, 2025. The filing also reports a grant of 4,111 new RSUs that will vest on the earlier of the one-year anniversary of grant or the 2026 annual meeting, subject to continued service. Following the reported transactions, the filing shows 23,871 shares of common stock beneficially owned and 4,111 RSUs outstanding as derivative securities.

Dynatrace director Jill A. Ward reported movements in her equity awards on Form 4. The filing records the reclassification of 3,981 time-based restricted stock units (RSUs) from non-derivative to derivative treatment and shows those 3,981 RSUs vested in full on August 20, 2025, converting into shares of common stock. Following the reported transactions, the reporting person beneficially owned 40,611 shares of common stock.

The Form 4 also discloses a new grant of 4,111 RSUs that will vest on the earlier of August 20, 2026 or the 2026 annual meeting, subject to continued service. Each RSU represents a contingent right to receive one share and carries $0 exercise price until settlement.

Stephen J. Lifshatz, a director of Dynatrace, Inc. (DT), reported changes to his equity holdings on 08/20/2025. The filing shows certain previously reported unvested time-based restricted stock units (RSUs) totaling 3,981 shares were moved from the non-derivative table to the derivative table to reflect their status as RSUs. Those RSUs, originally granted on 08/23/2024, 100% vested on 08/20/2025. The report also discloses a new grant of 4,111 RSUs that will vest on the earlier of the one-year anniversary of the grant (on or about 08/20/2026) or the 2026 annual meeting, subject to continued service. The filing is a routine disclosure of director equity movement and new RSU awards, showing the conversion and issuance mechanics rather than market sales or purchases.